Alpha-defensin peptide (None standardized for the family; individual peptides have common abbreviations such as HNP-1, HNP-2, HNP-3 (Human Neutrophil Peptides), HD5, HD6 (Human Defensin 5 and 6))

Molecular Classification

Antimicrobial peptide, Host defense peptide, Immune system effector

Other Names

Human neutrophil peptide 1, 2, 3, 4 (HNP-1, HNP-2, HNP-3, HNP-4), Human defensin 5, 6 (HD5, HD6), Cryptdin (mainly in mice)

Disease Roles

Infection (particularly antibiotic-resistant bacteria and viruses)Inflammation (chronic inflammatory conditions; psoriasis, wound healing)Cancer (increased levels in some cancers, e.g., colorectal cancer)

Alpha-defensin peptide Overview

Alpha-defensin peptides are a subclass of defensins, small cationic peptides (18–45 amino acids; 2–6 kDa), characterized by six conserved cysteines forming three intramolecular disulfide bonds and a beta-sheet-rich amphipathic structure. They are mainly found in mammalian leukocytes (neutrophils) and intestinal Paneth cells, mediating broad-spectrum antimicrobial and immunomodulatory actions. Alpha-defensins can directly disrupt microbial membranes and neutralize toxins, while also modulating immune responses, including chemotaxis, cytokine release, and regulation of cell death. Altered expression is associated with disease pathology in infections, inflammation, cancer, and autoimmune conditions. Alpha-defensins and their synthetic mimetics (such as brilacidin) are being developed as novel antibiotics, and alpha-defensin levels are under investigation as clinical biomarkers for disease risk and activity. Therapeutic development faces challenges due to the complex and sometimes double-edged role of defensins in human health.

Mechanism of Action

Direct membrane disruption via binding to negatively charged microbial membranes, leading to permeabilization and cell death Inhibition of microbial cell wall synthesis Neutralization of pathogenic proteins and toxins Immunomodulation (cytokine release, cell maturation, chemotaxis)

Biological Functions

Antimicrobial activity (against bacteria, fungi, viruses)

Immune response modulation (chemotaxis, maturation of dendritic cells, regulation of cytokine secretion, B cell proliferation)

Mucosal barrier protection

Regulation of cell death and autoimmunity

Neutralization of toxins (e.g., anthrax exotoxin)

Disease Associations

Infection (particularly antibiotic-resistant bacteria and viruses)

Inflammation (chronic inflammatory conditions; psoriasis, wound healing)

Cancer (increased levels in some cancers, e.g., colorectal cancer)

Skin disorders (acne)

Autoimmune disease (e.g., Crohn's disease)

Neuropsychiatric disease (possible involvement in schizophrenia)

Safety Considerations

Dual role in host immunity: while protective, defensins can, in certain biological contexts, promote infections and inflammation.
Increased expression can contribute to chronic inflammatory disease or tissue damage.
Imbalance may be linked to autoimmune disorders (e.g., Crohn's disease, psoriasis).

Interacting Drugs

Defensin mimetics, such as brilacidin (synthetic defensin-like molecule developed as an antibiotic and anti-inflammatory)

Conventional antibiotics (defensins can potentiate their action)

No approved drugs directly target native alpha-defensin peptides yet.

Associated Biomarkers

Biomarker
Alpha-defensin levels in various tissues or fluids serve as biomarkers for:
Infection risk
Chronic inflammation
Certain cancers (e.g., colorectal cancer)
Potential markers for neuropsychiatric disease risk (e.g., schizophrenia)
Crohn's disease (reduction in ileal defensins)